CN1799582A - Blood sugar- and blood pressure-lowering medicine - Google Patents
Blood sugar- and blood pressure-lowering medicine Download PDFInfo
- Publication number
- CN1799582A CN1799582A CN 200510012909 CN200510012909A CN1799582A CN 1799582 A CN1799582 A CN 1799582A CN 200510012909 CN200510012909 CN 200510012909 CN 200510012909 A CN200510012909 A CN 200510012909A CN 1799582 A CN1799582 A CN 1799582A
- Authority
- CN
- China
- Prior art keywords
- blood
- medicine
- radix
- blood sugar
- kilograms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention provides a medicament for lowering blood sugar and blood pressure, which is prepared from Ningtiao flower, mulberry leaf, ginkgo leaves, astragalus root, seabuckthorn leaf, wild jujuba seeds, poria cocos, notoginseng, tartary buckwheat and root of red rooted saliva.
Description
Technical field
The present invention relates to a kind of Chinese Traditional Medicines, specifically is the medicine of a kind of blood sugar lowering, blood pressure lowering.
Background technology
Diabetes be a kind of be the endocrine metabolism disease of feature with sugar, fat and protein metabolism disorder, the endocrine-metabolic disease of lifelong participation, its chronic complicating diseases ordinary wave and each system of whole body, serious harm human health.The topmost pathological change of diabetes is pancreas beta Cell of islet distortion, and downright bad β cytoactive reduces, and quantity reduces, and the corresponding minimizing of amount of insulin secretion causes in the blood blood glucose composition higher.Along with the aging of world population, it has been the third-largest disease after cardiovascular disease and cancer in developed country that diabetes have become death toll that a kind of commonly encountered diseases, frequently-occurring disease, particularly diabetic complication cause.
Current treatment diabetes insulin commonly used or oral antidiabetic drug treatment, though curative effect is definite, multiaction is in single target spot, and following problem is arranged: the biguanide drug curative effect is low, side effect is big, for a long time with producing hyperlactacidemia; Sulfaurea drugs is for a long time with infringement liver, kidney and hemocyte, and with the sulphonamides cross allergy, the later stage produces secondary failure; With producing antibody, biological activity reduces insulin for a long time, and dosage increases, and produces hyperinsulinemia, impels vascular lesion to take place and development.
Though the Chinese patent medicine of some treatment diabetes is also arranged, because effect is not fairly obvious, the patient still need rely on some Western medicine, as insulin etc.In addition, must sugaring just can impel the disintegrate of medicine grain usually in the electuary of Chinese patent medicine, then contain Mel in the honeyed pill, these dosage forms all are not suitable for diabetics and use.
Summary of the invention
The present invention reaches the problem of some Chinese medicine poor effect greatly and provides a kind of blood sugar lowering, the health medicine of blood pressure lowering in order to solve the Western medicine side effect in existence aspect the treatment diabetes of the prior art.
The present invention is realized by following technical scheme, a kind of blood sugar lowering, and the health medicine of blood pressure lowering is by the preparation by weight of following component:
Flos Caraganae intermediae 130-260 part, Folium Mori 20-40 part, Folium Ginkgo 25-45 part, Radix Astragali 10-20 part,
Folium Hippophae 15-33 part, Semen Ziziphi Spinosae 2-5 part, Poria 5-8 part, Radix Notoginseng 5-10 part,
Radix Et Rhizoma Fagopyri Tatarici 15-30 part, Radix Salviae Miltiorrhizae 10-25 part
Above-mentioned each medicine carries out respectively mixing after drying, the grinding and processing and gets final product.
Its powder of making can be done multiple dosage form and take.
Herba Caraganae intermediae is the common name of pulse family population pattern change cultivar.Flos Caraganae intermediae contain medicinal component as, flavone, alkaloid, Saponin etc.The energy promoting blood circulation by removing wind, blood pressure lowering, blood sugar lowering, treatment dizziness and tinnitus, symptoms such as infantile dyspepsia.
Folium Mori contain alkaloid 1-deoxynojirimycin, Mulberry polyphenol, Folium Mori total polysaccharides, superoxide dismutase and multivitamin and trace element.The energy blood sugar control enters quantity and the speed in the blood, and blood sugar regulation improves anti-sugar amount and strengthens the synthetic and excreting insulin of islet function promotion islet cells.
The Radix Astragali; contain polysaccharide, monosaccharide, flavonoid, betanin, folic acid, several amino acids, phlegmatic temperament, natural gum, cellulose and trace element-selenium, silicon etc.; to the stimulating central nervous system system, strengthen reticuloendothelial system phagocytic function, disease resistance enhancemen, improve cardio-pulmonary function, blood vessel dilating, bring high blood pressure down, improve cutaneous circulation and nutriture, the liver protecting, prevent that glycogen from reducing, promoting aspects such as the metabolism, diuresis, strong kidney, blood sugar lowering, calmness, antiviral, sterilization of cell, all has good effect.Because the Radix Astragali contains abundant trace element-selenium, also has the effect of good anticancer and prevention coronary heart disease.
Fructus Hippophae can blood lipid regulation, reduces cholesterolemia, prevents atherosclerosis, the effect of prevention coronary heart disease, cerebral thrombosis, liver cirrhosis, diabetes.
Semen Ziziphi Spinosae contains volume fatty oil and protein and triterpenoid, as betulin, and betulic acid, jujuboside and multivitamin.Tranquilizing soporific is arranged, analgesia, convulsion, the function of blood pressure lowering.
Poria has diuresis, effect in reducing blood glucose.
Radix Notoginseng suppresses virus, blood pressure lowering, the permeability of reduction blood capillary, the drag of increase blood capillary.
Radix Et Rhizoma Fagopyri Tatarici contains protein 11 .82g/100g, is rich in mineral elements such as potassium, sodium, magnesium, calcium, phosphorus, ferrum and zinc, copper, manganese, selenium and other trace elements, and contains flavone, has blood pressure lowering, effect in reducing blood glucose, and extensive plantation or growth are arranged in the whole nation.
Radix Salviae Miltiorrhizae has blood vessel dilating, brings high blood pressure down, and calmness, antibiotic, the effect of blood sugar lowering.
Blood pressure lowering of the present invention; the health medicine selection uniqueness of blood glucose; each material reasonable mixture ratio; resultant effect is remarkable; can promote the synthetic of interior insulin and discharge; reduce the effect of outer insulin periphery drag; protection islet cells and tissue, microcirculation improvement prevents the generation and the development of various vitals complication; promote the metabolism of sugar; reduce fat, proteinic decomposition, make blood glucose, blood fat reduces; to the control of diabetes, effective disease controlling, improving patients ' life quality has good result.
(1) functional components of medicine of the present invention and nutritional labeling
1, protein and aminoacid
Contain many functional mass and rich nutrient contents in the medicine of the present invention, wherein plant protein content can reach more than 15%, and contain 18 seed amino acids: comprising aspartic acid, threonine, serine, glutamic acid, proline, glycine, alanine, cystine, valine, methionine, isoleucine, leucine, tyrosine, phenylalanine, lysine, histidine, arginine, tryptophan, wherein arginine reaches 2.07%, lysine reaches 0.89%, leucine 1.18%, the necessary aminoacid of human body totally can promote the release of insulin, arginine particularly, lysine and leucine effect are the strongest, and each amino acid composition content sees Table 1 in the preparation of the present invention.
Table 1 medicine amino acid content of the present invention
| Title | Content % | Title | Content % | Title | Content % |
| Aspartic acid | 1.16 | Alanine | 0.78 | Tyrosine | 0.42 |
| Threonine | 0.6 | Cystine | 0.11 | Phenylalanine | 0.76 |
| Serine | 0.55 | Valine | 0.92 | Lysine | 0.89 |
| Glutamic acid | 2.10 | Methionine | 0.05 | Histidine | 0.27 |
| Proline | 0.53 | Isoleucine | 0.68 | Arginine | 2.07 |
| Glycine | 0.77 | Leucine | 1.18 | Tryptophan | 0.15 |
2, mineral element
Is that main making in the blood sugar lowering depressor of the present invention also contained several kinds of mineral elements such as calcium, magnesium, phosphorus, ferrum, zinc, selenium with the Flos Caraganae intermediae, these elements are the prothetic groups that constitute the multiple metalloenzyme of body, to the biosynthesis of insulin and discharged catalytic action.Each mineral element content sees Table 2 in the preparation of the present invention.
Table 2 medicine mineral element of the present invention content
| Title | Content % | Title | Content % | Title | Content % |
| Calcium | 2.39 | Phosphorus | 0.27 | Ferrum | 0.904 |
| Magnesium | 0.65 | Selenium | 0.02 | Zinc | 0.056 |
3, active ingredient of natural product
Find through efficient liquid phase chromatographic analysis, contain abundant flavonoids such as hyperin, rutin, isoquercitin, Quercetin, morin etc. in the medicine of the present invention, and contain bioactive ingredients such as chlorogenic acid, resveratrol, ursolic acid, oleanolic acid.Wherein according to the proportioning difference; flavone compound content in preparation is 2～3%; flavone compound except can blood fat reducing, blood viscosity, promotion microcirculation, increase the islets of langerhans blood perfusion; help beyond the synthetic and secretion of insulin; all right hepatic cholagogic; anticoagulation, antitumor, resisting hypertension, angina pectoris, the protection cardiovascular and cerebrovascular vessel, and analgesic activity is arranged.Chlorogenic acid is a G1-6-P displacement enzyme inhibitor, the glycogen that helps reducing noninsulindependent diabetes is drained too fast, removes functions such as free radical, anti peroxidation of lipid, antimutagenic, cardiovascular effect, hepatic cholagogic, antibiotic, antiviral and spasmolytic in addition in addition.That resveratrol has is anticancer, cardiovascular protection, antioxidation, free radical resisting, neuroprotective, antiinflammatory, protect the liver, the blood fat reducing isoreactivity.That ursolic acid has is anticancer, liver injury protection, anti-inflammation and antiviral function.Oleanolic acid then has and protects the liver the function of protecting kidney and anti HIV-1 virus.
Also containing exclusive alkaloid 1-deoxynojirimycin (DNJ) in the medicine of the present invention, can suppress blood glucose value and raise and cholesterol absorption, is the jinx of diabetes.Contained sitosterol, stigmasterol, triterpenoid compound, γ-An Jidingsuan (GABA) are the bases of the necessary sterin of synthesized human, can alleviate even eliminate hepatocellular degeneration and necrosis, promote hepatocellular regeneration, and have neurotransmitter and hypotensive effect.
These active ingredient of natural product comprehensive coordination effects, blood pressure lowering, blood sugar lowering approach are various, act on many target spots, effective disease controlling, minimizing and diabetes-alleviating, hypertensive complication.
Active ingredient of natural product in table 3 medicine of the present invention contains scale
| Flavone compound | Content (%) | Other chemical compound | Content (%) |
| Hyperin | 0.280 | Chlorogenic acid | 0.107 |
| Rutin | 1.241 | Resveratrol | 0.110 |
| Isoquercitin | 0.368 | Oleanolic acid | 0.069 |
| Morin | 0.132 | Ursolic acid | 0.045 |
| Quercetin | 0.253 | The triterpene olefin(e) acid | 0.152 |
| Isorhamnetin | 0.085 | The 1-deoxynojirimycin | 0.084 |
| Nimbecetin | 0.124 | ||
| Luteolin | 0.043 |
Annotate: the medicament with this description embodiment preparation is a working sample
The zoopery result
(2) medicine of the present invention is to the hypoglycemic activity of diabetes rat
1.1 the extraction of effective ingredient of the present invention
Get drug powder of the present invention and use 95%, 70%, 50%, 30% edible ethanol heating and refluxing extraction respectively, merge each extracting solution, filter, concentrating under reduced pressure removes chlorophyll, is concentrated into extractum.The extractum water is mixed with the diluent of 0.8g (crude drug)/mL, and is standby.
1.2 preparation diabetes rat model
50 of SD rats weigh 195.3 ± 6.4g, and male and female are not limit, and feed before the experiment one week of normal feedstuff.Be divided into 5 groups at random: A. normal control group, B. diabetes model matched group, the medicine group of the present invention of C, D, E. different dosing level.10 of every group of laboratory animals, single cage is raised, and freely drinks water and ingests.
1.3 observation hypoglycemic activity
Above-mentioned 5 groups of rats are gastric infusion respectively.A group: normal saline; B group: normal saline; C, D, the E group:
The drug extract diluent of the present invention of various dose continues to feed, and the rat blood sugar situation of change respectively organized in record simultaneously, carries out carbohydrate tolerance test after 0 week, 4 weeks, 8 weeks.
1.4 result
Result of the test shows (table 4, table 5), drug extract diluent of the present invention is to the administration of diabetes model rat oral gavage, rat blood sugar reduces than normal control group after 8 weeks, C group rat fasting blood-glucose is on average reduced to 9.26mmol/L by the 16.91mmol/L before the administration, the average 7.65mmol/L that reduces, D group rat fasting blood-glucose is on average reduced to 5.78mmol/L by the 16.35mmol/L before the administration, the average 10.57mmol/L that reduces, E group rat fasting blood-glucose is on average reduced to 4.23mmol/L by the 16.71mmol/L before the administration, the average 12.48mmol/L that reduces is all extremely remarkable with model control group difference.30min blood sugar increasing value is compared remarkable decline with the hyperglycemia matched group after the meal, and glucose tolerance curve improves, and effect is quite remarkable.
Table 4 drug extract diluent of the present invention gastric infusion is to the influence of rat fasting blood-glucose
| Grouping | Fasting glucose mmol/L (X ± S), n=10 | ||
| 0 week | 4 weeks | 8 weeks | |
| A | 3.72±0.14 | 3.75±0.29 | 3.65±0.45 |
| B | 16.57±2.32 | 16.69±1.78 | 16.43±2.19 |
| C | 16.91±1.25 | 13.32±2.45 | 9.26±1.86 |
| D | 16.35±3.57 | 12.31±1.39 | 5.78±1.14 |
| E | 16.71±2.14 | 10.68±3.46 | 4.23±0.67 |
Table 5 drug extract diluent of the present invention gastric infusion is to the influence of rat carbohydrate tolerance
| Grouping | Carbohydrate tolerance mmol/L (X ± S), n=10 | |||
| 0min | 30min | 60min | 120min | |
| A | 3.65±0.45 | 5.69±0.39 | 4.25±0.58 | 3.72±0.21 |
| B | 16.43±2.19 | 19.37±4.31 | 17.28±2.64 | 16.82±3.47 |
| C | 9.26±1.86 | 12.58±2.56 | 10.68±1.99 | 9.37±2.49 |
| D | 5.78±1.14 | 7.23±2.12 | 5.99±2.07 | 5.48±1.74 |
| E | 4.23±0.67 | 5.64±0.75 | 5.02±1.2 | 4.52±0.71 |
(3) toxicity test of medicine of the present invention
Give 10 rat oral gavage drug extracts of the present invention, dosage is equivalent to 50g/kg, and the rat spontaneous activity reduces after the administration, recovers normal behind 5～6h, observes 5d continuously, and none death illustrates that this product toxicity is very little.
(4) advantage of medicine of the present invention
(1) this preparation selects for use the homologous plant tissue of medicated diet as raw material, utilizes comprehensive function prevention, the treatment diabetes of contained special effective ingredient of plant tissue and prescription, does not have chemical sweeting agent, and is nontoxic to human body, is fit to take for a long time.
(2) this preparation need not to decoct, and no bitterness sense is nutritious, and taking convenience meets state food health legislation regulation.
(3) the light disease person of this preparation can use separately.Can use with other antidiabetic drugs and insulin combination than serious symptom person, but can gradually reduce the use amount of antidiabetic drug and insulin, effect obviously increases, and can significantly alleviate or eliminate other complication, increases immunity of organisms, improves the patient body situation.
Flos Caraganae intermediae can drive the plantation of Herba Caraganae intermediae, can conserve water and soil, and beautifies the environment, and promotes local economic development.
(5) the medical effect statistical result of medicine of the present invention is as follows:
(1), diabetics 100 examples: wherein male 20 examples, women 80 examples; (2) hyperpietic's 20 examples: wherein male 15 examples, women 5 examples; (3) other patient's 5 examples: wherein male 4 examples, women 1 example.
1 course of treatment of capsule (30 days) of diabetes and complication patient health medicine preparation of the present invention, every day 3 times, each 6 effect observation.See the following form
(5) model case
Xu XX, the woman, 70 years old, Shanxi Province the 3rd worker of hydrological team suffered from diabetes 17 years.
Main disease: 1. sleep is bad; 2. legs and feet edema, unable, the general fatigue of both legs; 3. take Western medicine for a long time and cause gastrointestinal upset; 4. blurred vision.
Began to take the Flos Caraganae intermediae blood sugar lowering depressor capsule preparations that the present invention makes, every day 3 times, each 4, onset in 7 days in 2003,1 the course of treatment health improve comprehensively, health is salubrious, sleep is steady and sure, legs and feet edema sx, walk energetically, gastrointestinal function takes a turn for the better, and it is clearer to look thing.
Open XX, the woman, 37 years old, unemployed, lived in Yuci District Liu Bei lane, Jinzhong City, suffered from diabetes 7 years.Take 1 course of treatment of Flos Caraganae intermediae blood sugar lowering depressor capsule preparations that the present invention makes, every day 3 times, each 4, the intestines and stomach takes a turn for the better, and looks thing and becomes clear, and health is salubrious.
Lee XX, woman, 53 years old, the Sorghum vulgare Pers. institute worker of academy of agricultural sciences, Shanxi Province.Suffered from diabetes 21 years, insulin injection 17 years.The long-term pruritus of skin, ulcer all takes place every month in the oral cavity, needs three days ability of transfusion to take a turn for the better, and it is bad to sleep, and it is very dry to defecate, and hypoglycemia often takes place, puffiness of face, malaise.
Began to take the Flos Caraganae intermediae blood sugar lowering depressor capsule preparations that medicine of the present invention is made on August 12nd, 2002, every day 3 times, each 10, hypoglycemia does not take place in 100 days.Just began in 7 days to take a turn for the better, 1 the course of treatment skin pruritus alleviate, oral ulcer is clearly better, or else very fast Lock-out after taking place sometimes uses infusion treatment, health is obviously improved.Skin recovers normally do not have aphtha fully now, and stool is normal, and can also play table tennis every afternoon.
White XX, the man, 53 years old, the worker of Taigu County public security bureau suffered from diabetes 5 years, took Western medicine for a long time, began to take the Flos Caraganae intermediae blood sugar lowering depressor capsule preparations that medicine of the present invention is made in November, 2004, clothes back free movement of the bowels, health is salubrious, and spirit takes a turn for the better.
Field XX, woman, 59 years old, Taiyuan Iron and Steel Co. retired employees.Suffered from hypertension 5 years, fluctuation of blood pressure is in 170～150mmHg/110～100mmHg.Blood glucose is higher, and fasting glucose fluctuates at 7.9～9.5mmol/L.Once took medicines such as Herba Apocyni veneti (Folium Apocyni Veneti) Tabellae, compound rutin, glipizide.Rise in August, 2004, and divide every day and take the Flos Caraganae intermediae blood sugar lowering depressor capsule preparations that medicine of the present invention is made for 3 times, each 6, blood pressure 155～145mmHg/100～80mmHg after a year, fasting glucose 5.6～5.9mmol/L, subjective symptoms disappears substantially.
Open XX, man, 45 years old, the worker of Taiyuan Cigarette Factory.Blood pressure fluctuates for a long time in 150～130mmHg/86mmHg, fasting glucose 6.4mmol/L.From in February, 2005, divide every day and take the Flos Caraganae intermediae blood sugar lowering depressor capsule preparations that medicine of the present invention is made for 3 times, each 4, blood pressure is stabilized in 120～110mmHg/80～70mmHg after 7 months, fasting glucose 5.2mmol/L, the oral ulcer, the halitosis phenomenon that often occur before taking medicine disappear substantially.
King XX, woman, 51 years old, the corn institute scientific and technical personnel of academy of agricultural sciences, Shanxi Province ill 6 years, liied in bed 2 years, through examination in hospital such as Xinzhou, Taiyuan, be diagnosed as hyperthyroidism, brain atrophy, treated poor effect 6 years, after Beijing 301 Hospital checks, negate the check result in early stage comprehensively, but do not make a definite diagnosis the cause of disease, can't take care of oneself so far.
Began to take the Flos Caraganae intermediae blood sugar lowering depressor capsule preparations that medicine of the present invention is made on March 12nd, 2004, every day 3 times, each 5, played spirit and get better in 7 days.
Become XX, man, 53 years old, the Sorghum vulgare Pers. institute scientific and technical personnel of academy of agricultural sciences, Shanxi Province.Suffered from coronary heart disease 7 years, the both legs knee joint was sprained repeatedly in 1998, and the pain of walking on August 13rd, 2002 began to take lemon flower blood sugar lowering depressor capsule preparations unbearably, and every day 3 times, each 10, double knee joint takes a turn for the better after 2 months, 100 days pain completely without.No matter large dose oral administration Flos Caraganae intermediae blood sugar lowering depressor capsule preparations was that cold water is taken or hot water is taken more than 2 years, and untoward reaction does not all take place.
The specific embodiment
Embodiment 1:
Take by weighing 7 kilograms of 7 kilograms of Radix Salviae Miltiorrhizaes of 3 kilograms of Radix Et Rhizoma Fagopyri Tatarici of 2 kilograms of Radix Notoginseng of 1 kilogram of Poria of 7 kilograms of Semen Ziziphi Spinosaes of 5 kilograms of Folium Hippophae of 10 kilograms of Radixs Astragali of 10 kilograms of Folium Ginkgos of 50 kilograms of Folium Mori of Flos Caraganae intermediae
120 order fine powders are made in dry respectively, pulverizing; Obtain powder behind the mix homogeneously, can make capsule and take.The glue capsule is an existing conventional technology.
Embodiment 2: take by weighing 10 kilograms of 15 kilograms of Radix Salviae Miltiorrhizaes of 5 kilograms of Radix Et Rhizoma Fagopyri Tatarici of 5 kilograms of Radix Notoginseng of 2 kilograms of Poria of 15 kilograms of Semen Ziziphi Spinosaes of 10 kilograms of Folium Hippophae of 25 kilograms of Radixs Astragali of 25 kilograms of Folium Ginkgos of 130 kilograms of Folium Mori of Flos Caraganae intermediae, 80 order fine powders are made in dry respectively, pulverizing; Obtain powder behind the mix homogeneously, can make capsule and take.
Embodiment 3: take by weighing 25 kilograms of 30 kilograms of Radix Salviae Miltiorrhizaes of 10 kilograms of Radix Et Rhizoma Fagopyri Tatarici of 8 kilograms of Radix Notoginseng of 5 kilograms of Poria of 33 kilograms of Semen Ziziphi Spinosaes of 20 kilograms of Folium Hippophae of 45 kilograms of Radixs Astragali of 40 kilograms of Folium Ginkgos of 260 kilograms of Folium Mori of Flos Caraganae intermediae, 60 order fine powders are made in dry respectively, pulverizing; Obtain powder behind the mix homogeneously, can also make tablet, the watered pill, or honeyed pill also can further be processed as oral formulations.
Claims (2)
1, a kind of blood sugar lowering, the medicine of blood pressure lowering is characterized in that, it is formulated by weight by following component:
Flos Caraganae intermediae 130-260 part, Folium Mori 20-40 part, Folium Ginkgo 25-45 part, Radix Astragali 10-20 part, Folium Hippophae 15-33 part, Semen Ziziphi Spinosae 2-5 part, Poria 5-8 part, Radix Notoginseng 5-10 part, Radix Et Rhizoma Fagopyri Tatarici 15-30 part, Radix Salviae Miltiorrhizae 10-25 part.
2, blood sugar lowering according to claim 1, the medicine of blood pressure lowering is characterized in that, it is formulated by weight by following component:
Flos Caraganae intermediae 150-220 part, Folium Mori 25-35 part, Folium Ginkgo 30-40 part, Radix Astragali 15-20 part, Folium Hippophae 20-30 part, Semen Ziziphi Spinosae 3-5 part, Poria 5-8 part, Radix Notoginseng 6-9 part, Radix Et Rhizoma Fagopyri Tatarici 20-25 part, Radix Salviae Miltiorrhizae 15-20 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200510012909XA CN1329049C (en) | 2005-10-12 | 2005-10-12 | Blood sugar- and blood pressure-lowering medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200510012909XA CN1329049C (en) | 2005-10-12 | 2005-10-12 | Blood sugar- and blood pressure-lowering medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1799582A true CN1799582A (en) | 2006-07-12 |
| CN1329049C CN1329049C (en) | 2007-08-01 |
Family
ID=36809941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200510012909XA Expired - Fee Related CN1329049C (en) | 2005-10-12 | 2005-10-12 | Blood sugar- and blood pressure-lowering medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1329049C (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102630790A (en) * | 2012-05-08 | 2012-08-15 | 四川九通慧医药信息科技有限公司 | Tartary buckwheat tea prepared by Ginkgo biloba leaf and preparation process thereof |
| CN102669360A (en) * | 2012-05-04 | 2012-09-19 | 蓝照斓 | Caragana microphylla flower healthcare tea |
| CN103519081A (en) * | 2013-10-24 | 2014-01-22 | 合肥市香口福工贸有限公司 | Method for processing corn mixed cake for reducing blood pressure |
| CN103518880A (en) * | 2013-09-27 | 2014-01-22 | 安徽省林锦记食品工业有限公司 | Honey tea drink for strengthening spleen and stomach as well as production method of drink |
| CN105919096A (en) * | 2016-05-16 | 2016-09-07 | 西藏康德生物科技有限公司 | Healthcare food composition and preparation and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1194730C (en) * | 2002-07-08 | 2005-03-30 | 王汝明 | Cardiac and cerebral blood vessel nourishing tea |
| CN1278715C (en) * | 2004-12-30 | 2006-10-11 | 中国人民解放军海军青岛疗养院 | Medication for treating diabetes |
-
2005
- 2005-10-12 CN CNB200510012909XA patent/CN1329049C/en not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102669360A (en) * | 2012-05-04 | 2012-09-19 | 蓝照斓 | Caragana microphylla flower healthcare tea |
| CN102669360B (en) * | 2012-05-04 | 2013-10-30 | 蓝照斓 | Caragana microphylla flower healthcare tea |
| CN102630790A (en) * | 2012-05-08 | 2012-08-15 | 四川九通慧医药信息科技有限公司 | Tartary buckwheat tea prepared by Ginkgo biloba leaf and preparation process thereof |
| CN102630790B (en) * | 2012-05-08 | 2015-02-11 | 四川九通慧医药信息科技有限公司 | Tartary buckwheat tea prepared by Ginkgo biloba leaf and preparation process thereof |
| CN103518880A (en) * | 2013-09-27 | 2014-01-22 | 安徽省林锦记食品工业有限公司 | Honey tea drink for strengthening spleen and stomach as well as production method of drink |
| CN103519081A (en) * | 2013-10-24 | 2014-01-22 | 合肥市香口福工贸有限公司 | Method for processing corn mixed cake for reducing blood pressure |
| CN105919096A (en) * | 2016-05-16 | 2016-09-07 | 西藏康德生物科技有限公司 | Healthcare food composition and preparation and application thereof |
| CN105919096B (en) * | 2016-05-16 | 2020-05-22 | 西藏海容唐果健康产业有限公司 | Health food composition, preparation and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1329049C (en) | 2007-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103285231A (en) | Medicine composition for diabetes adjunctive therapy and preparation method thereof | |
| CN101612315A (en) | A kind of compound Chinese medicinal preparation that is used to adjust function of human body | |
| CN1723981A (en) | Novel use of extractive of Momordica grosvenori as adjuvant drug for preparing medicine | |
| CN101461896A (en) | Chinese medicinal composition assistant for reducing blood fat and preparation method thereof | |
| CN1299742C (en) | Medicine for treating diabetes, and its prepn. method | |
| CN1899342A (en) | Oral medicine for treating diabetes and its use | |
| CN1329049C (en) | Blood sugar- and blood pressure-lowering medicine | |
| CN101856405B (en) | Medicinal composition for treating type II diabetes mellitus and preparation method thereof | |
| CN104857154A (en) | Traditional Chinese medicine composition for treating three-high diseases and preparation method therefor | |
| CN1565467B (en) | Use of cornel and its extract in preparation alpha-glucosidase inhibitor medicine | |
| CN107648330B (en) | Blood sugar reducing composition based on nigella sativa and mongolian medicine for reducing blood sugar | |
| CN113616688B (en) | Anserine composition for repairing kidney injury and application thereof | |
| CN102743646B (en) | Medicinal composition for inspecting and preventing diabetes | |
| CN101491605A (en) | Combination with blood sugar reducing function and preparation method thereof | |
| CN101336965A (en) | Chinese prepared medicine for improving sugar tolerance and reducing blood sugar and preparation method thereof | |
| CN101433597A (en) | Chinese medicinal composition with function for reducing blood sugar and preparation method thereof | |
| CN1087627C (en) | Medicament for treating diabetes and its preparation method | |
| CN113456778A (en) | Composition for improving energy and preparation method thereof | |
| CN101491668A (en) | Composite with blood-sugar reducing function and preparation method thereof | |
| CN1272054C (en) | Medicine for treating diabetes and its preparing process | |
| CN101120969A (en) | Medicine for treating diabetes and its complications and preparing method thereof | |
| CN100453073C (en) | Compound radical lobelia dripping pill and its preparing method | |
| CN1182862C (en) | Chinese medicine prepn for treating coronary heart disease and angina pectoris and its prepn | |
| CN100353948C (en) | Prescription for treating type 2 diabetes and its preparing method | |
| CN102631486B (en) | Health care composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070801 Termination date: 20091112 |